On Jan. 14, 2026, U.S. healthcare spending rose by 7.2% to $5.3 trillion in 2024 from $4.9 trillion…
On Jan. 13, 2026, collaborating with Google’s top artificial intelligence labs, a team of Yale researchers announced they…
On Jan. 12, 2026, AbbVie announced a voluntary agreement with the Trump administration to further advance access and…
On Jan. 12, 2026, AbbVie and West Pharmaceutical Services announced a definitive agreement for AbbVie to acquire a…
On Jan. 9, 2026, Novartis announced plans to build its fourth US radioligand therapy (RLT) manufacturing facility in…
On Jan. 8, 2026, for the first time, researchers at the University of British Columbia have demonstrated how…
On Jan. 8, 2026, Chinese drug makers’ licensing deals more than doubled in 2025 from a year earlier…
On Jan. 7, 2025, Eli Lilly and Ventyx Biosciences, a San Diego-based clinical-stage biopharmaceutical company focused on developing…
On Jan. 6, 2026, a study led by University of Washington School of Medicine researchers uncovered several new…
On Jan. 5, 2026, Novo Nordisk announced that the Wegovy® pill is now available, providing those seeking help…
On Dec. 22, 2025, Novo Nordisk announced announced that the US Food and Drug Administration (FDA) has approved…
On Dec. 21, 2025, Samsung Biologics announced that its wholly owned U.S. subsidiary, Samsung Biologics America, has entered…
On Dec. 19, 2025, Cytokinetics announced that the U.S. Food and Drug Administration (FDA) has approved MYQORZO™ (aficamten),…
On Dec. 19, 2025, Novartis, a leading global innovative medicines company, announced it has reached an agreement with…
On Dec. 18, 2025, the World Health Organization (WHO) announced it has validated Brazil for the elimination of…
On Dec. 18, 2025, new national and state data was released by the Partnership to Fight Chronic Disease…
On Dec. 18, 2025, the National Aeronautics and Space Administration (NASA) announced it has opened the International Space…
On Dec. 18, 2025, Novo Nordisk announced the submission of a New Drug Application (NDA) to the U.S….
On Dec. 18, 2025, scientists at the Hebrew University of Jerusalem revealed that bacteriophages use a small RNA…
On Dec. 17, 2025, researchers at the University of Pennsylvania’s (UPenn) School of Engineering and Applied Science, and…
On Dec. 15, 2025, Adaptive Biotechnologies announced it has signed two non-exclusive deals with Pfizer to support research…
On Dec. 15, 2025, the U.S. Department of Commerce announced that Montana State University will be home to…
On Dec. 12, 2025, a Japanese research team announced it has successfully reproduced the human neural circuit in…
On Dec. 12, 2025, the U.S. Food and Drug Administration (FDA) announced it has approved two new oral…
On Dec. 11, 2025, the California Institute for Regenerative Medicine (CIRM) governing board approved funding of over $160…
On Dec. 11, 2025, USAntibiotics, the country’s only domestic manufacturer of amoxicillin (Amoxil®) and amoxicillin clavulanate (Augmentin®), announced…
On Dec. 9, 2025, Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved the…
On Dec. 9, 2025, researchers at the UCLA Health Jonsson Comprehensive Cancer Center announced they have identified a…
On Dec. 9, 2025, officials from the Canada Economic Development for Quebec Regions, and the Minister of Industry,…
On Dec. 8, 2025, the U.S. Food and Drug Administration (FDA) approved two milestone treatments, Casgevy and Lyfgenia,…